Kat Racadio Joins Pinetree Capital as Director of Investor Relations

Financial Services Expert Joins the Pinetree Team

MAKATI CITY,  MAY 1, 2019 — Pinetree Capital announces Zheryll Katherine Racadio, a senior financial services executive with 18 years of experience, as its Director of Investor Relations. Ms. Racadio is responsible for ensuring Pinetree Capital is appropriately and strategically positioned with analysts, investors, and all stakeholders.

66453154_464235551035411_3628879969322532864_n.jpg

Director of Investor Relations | kat@pinetree.ph

Ms. Racadio specializes in retail banking, credit management, consumer lending, and corporate banking. She trained in numerous reputable international schools to build her skill in business and finance: a Masters’ Degree in Management from the Asian Institute of Management; a certificate in Business Excellence, as well as Global Banking from the Columbia Business School in New York.

Her superior training on disruptive innovation and comprehensive knowledge on business model innovations techniques adds to Pinetree Capital’s arsenal in identifying the most lucrative opportunities in financial technology, digital banking, and big data analytics.  She has held management roles in a number of organizations with diverse cultural, academic, and professional backgrounds; the likes of which include: Metropolitan Bank and Trust Company, Insular Home Credit, PS Bank, Rizal Commercial Banking Corporation (RCBC), and Maybank.  

At present, Kat Racadio proves her experience as she establishes sales strategies and strategic partnerships in emerging market economies in Southeast Asia and the United States.


About Pinetree Capital

Pinetree Capital (Pinetree.ph) is an association of Filipino Family Corporations and Filipino-founded Single Family Offices, with offices in the United States and Southeast Asia. Pinetree.ph’s investment interests range from traditional business models in real estate, healthcare, and financial services, to burgeoning businesses in spaces such as blockchain applications and digital therapeutics.